ArticleGastroenterology report2026

Recurrent local and systemic hypersensitivity reactions after switching back from subcutaneous to intravenous vedolizumab in ulcerative colitis: a case presentation.

Tomoyoshi Shibuya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.